TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients

Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner

(2014) L. Lan et al.   JOURNAL OF IMMUNOLOGY

Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C

(2011) Golo Ahlenstiel et al.   GASTROENTEROLOGY

Expression, Cellular Distribution, and Prognostic Relevance of TRAIL Receptors in Hepatocellular Carcinoma

(2010) L. Kriegl et al.   CLINICAL CANCER RESEARCH

Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation

(2010) Annie Yang et al.   CURRENT OPINION IN CELL BIOLOGY

Interferon-α–Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection

(2010) Kerstin A. Stegmann et al.   GASTROENTEROLOGY

Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer

(2009) Yulia M. Ulybina et al.   CANCER LETTERS

Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors

(2009) Kerstin Schütte et al.   DIGESTIVE DISEASES

TRAIL-R1 polymorphisms and cancer susceptibility: An evidence-based meta-analysis

(2009) Bo Chen et al.   EUROPEAN JOURNAL OF CANCER

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

(2009) Sean F. Altekruse et al.   JOURNAL OF CLINICAL ONCOLOGY

TRAILing death in cancer

(2009) Gregory Mellier et al.   MOLECULAR ASPECTS OF MEDICINE

Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer

(2008) Meilin Wang et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS